Thalibealine is primarily used in the pharmaceutical industry as an intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. It plays a role in the development of experimental neuroprotective agents and has shown potential in modulating neurotransmitter receptors involved in cognitive function. Due to its structural properties, it is also investigated for use in novel anti-inflammatory agents and as a scaffold in medicinal chemistry for drug design. Research applications include in vitro studies on neuronal cell lines to evaluate its effect on cellular signaling pathways. Its use remains largely restricted to laboratory and research settings, with no current approval for clinical or industrial applications outside experimental studies.